Literature DB >> 12068028

Cardiac involvement in Anderson-Fabry disease.

Christoph Kampmann1, Frank Baehner, Markus Ries, Michael Beck.   

Abstract

Mesh：

Year:  2002        PMID： 12068028

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  8 in total

1.  High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.

Authors:  A C Hauser; A Gessl; M Lorenz; T Voigtländer; M Födinger; G Sunder-Plassmann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

Authors:  B Hoffmann; A Garcia de Lorenzo; A Mehta; M Beck; U Widmer; R Ricci
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

4.  Clinical and biochemical studies in mucopolysaccharidosis type II carriers.

Authors:  I V D Schwartz; L L C Pinto; G Breda; L Lima; M G Ribeiro; J G Mota; A X Acosta; P Correia; D D G Horovitz; C G G Porciuncula; E Lipinski-Figueiredo; A C Fett-Conte; R P Oliveira Sobrinho; D Y J Norato; A C Paula; C A Kim; A R Duarte; R Boy; S Leistner-Segal; M G Burin; R Giugliani
Journal:  J Inherit Metab Dis       Date:  2009-10-10       Impact factor: 4.982

5.  Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.

Authors:  F Baehner; C Kampmann; C Whybra; E Miebach; C M Wiethoff; M Beck
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment.

Authors:  Christoph Kampmann; Amandine Perrin; Michael Beck
Journal:  Orphanet J Rare Dis       Date:  2015-09-29       Impact factor: 4.123

7.  Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease.

Authors:  Hideki Fujii; Keiji Kono; Tetsushi Yamamoto; Tetsuari Onishi; Shunsuke Goto; Kentaro Nakai; Hiroya Kawai; Ken-Ichi Hirata; Masafumi Fukagawa; Shinichi Nishi
Journal:  Clin Kidney J       Date:  2012-10-03

8.  Anderson-Fabry disease presenting with atrial fibrillation as earlier sign in a young patient: A case report.

Authors:  Hangyul Kim; Min Gyu Kang; Hyun Woong Park; Jeong-Rang Park; Jin-Yong Hwang; Kyehwan Kim
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.